Herpes simplex virus interference with immunity: Focus on dendritic cells

References

• Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.
   PubMed Web of Science ®Google Scholar
• Suazo PA, Ibanez FJ, Retamal-Diaz AR, Paz-Fiblas MV, Bueno SM, Kalergis AM, et al. Evasion of early antiviral responses by herpes simplex viruses. Mediators Inflamm. 2015;2015:593757.
   PubMed Web of Science ®Google Scholar
• Retamal-Diaz AR, Suazo PA, Garrido I, Kalergis AM, Gonzalez PA. [Immune evasion by herpes simplex viruses]. Rev Chilena Infectol. 2015;32(1):58–70.
   PubMed Web of Science ®Google Scholar
• Ship II, Ashe WK, Scherp HW. Recurrent “fever blister” and “canker sore” tests for herpes simplex and other viruses with mammalian cell cultures. Arch Oral Biol. 1961;3(2):117–IN11.
   PubMed Web of Science ®Google Scholar
• Kleger B, Prier JE, Rosato DJ, McGinnis AE. Herpes simplex infection of the female genital tract. I. Incidence of infection. Am J Obstet Gynecol. 1968;102(5):745–748.
   PubMed Web of Science ®Google Scholar
• Spicknall IH, Flagg EW, Torrone EA. Estimates of the prevalence and incidence of genital herpes, United States, 2018. Sex Transm Dis. 2021;48(4):260–265.
   PubMed Web of Science ®Google Scholar
• James C, Harfouche M, Welton NJ, Turner KM, Abu-Raddad LJ, Gottlieb SL, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315–329.
   PubMed Web of Science ®Google Scholar
• Looker KJ, Johnston C, Welton NJ, James C, Vickerman P, Turner KME, et al. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Health. 2020;5(3):e001875.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang R, Xu C, Zhou H. Pathogenesis of herpes stromal keratitis: immune inflammatory response mediated by inflammatory regulators. Front Immunol. 2020;11:766.
   PubMed Web of Science ®Google Scholar
• Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013;13(12):414.
   PubMed Web of Science ®Google Scholar
• Bradshaw MJ, Venkatesan A. Herpes Simplex Virus-1 Encephalitis in Adults: pathophysiology, Diagnosis, and Management. Neurotherapeutics. 2016;13(3):493–508.
   PubMed Web of Science ®Google Scholar
• Richart SM, Simpson SA, Krummenacher C, Whitbeck JC, Pizer LI, Cohen GH, et al. Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by Nectin-1/HveC. J Virol. 2003;77(5):3307–3311.
   PubMed Web of Science ®Google Scholar
• Adamiak B, Ekblad M, Bergstrom T, Ferro V, Trybala E. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells. J Virol. 2007;81(24):13424–13434.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin N, Viejo-Borbolla A, Martin R, Blanco S, Benovic JL, Thelen M, et al. Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization. Nat Commun. 2015;6(1):6163.
   PubMed Web of Science ®Google Scholar
• Whitbeck JC, Peng C, Lou H, Xu R, Willis SH, Ponce de Leon M, et al. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol. 1997;71(8):6083–6093.
   PubMed Web of Science ®Google Scholar
• Farnsworth A, Wisner TW, Webb M, Roller R, Cohen G, Eisenberg R, et al. Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane. Proc Natl Acad Sci U S A. 2007;104(24):10187–10192.
   PubMed Web of Science ®Google Scholar
• Ibanez FJ, Farias MA, Gonzalez-Troncoso MP, Corrales N, Duarte LF, Retamal-Diaz A, et al. Experimental Dissection of the Lytic Replication Cycles of Herpes Simplex Viruses in vitro. Front Microbiol. 2018;9:2406.
   PubMed Web of Science ®Google Scholar
• Duarte LF, Reyes A, Farias MA, Riedel CA, Bueno SM, Kalergis AM, et al. Crosstalk Between Epithelial Cells, Neurons and Immune Mediators in HSV-1 Skin Infection. Front Immunol. 2021;12:662234.
   PubMed Web of Science ®Google Scholar
• Duarte LF, Farias MA, Alvarez DM, Bueno SM, Riedel CA, Gonzalez PA. Herpes Simplex Virus Type 1 Infection of the Central Nervous System: insights Into Proposed Interrelationships With Neurodegenerative Disorders. Front Cell Neurosci. 2019;13:46.
   PubMed Web of Science ®Google Scholar
• Diefenbach RJ, Miranda-Saksena M, Douglas MW, Cunningham AL. Transport and egress of herpes simplex virus in neurons. Rev Med Virol. 2008;18(1):35–51.
   PubMed Web of Science ®Google Scholar
• Huang W, Xie P, Xu M, Li P, Zao G. The influence of stress factors on the reactivation of latent herpes simplex virus type 1 in infected mice. Cell Biochem Biophys. 2011;61(1):115–122.
   PubMed Web of Science ®Google Scholar
• Wisner TW, Sugimoto K, Howard PW, Kawaguchi Y, Johnson DC. Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol. 2011;85(12):5919–5928.
   PubMed Web of Science ®Google Scholar
• Ouwendijk WJ, Laing KJ, Verjans GM, Koelle DM. T-cell immunity to human alphaherpesviruses. Curr Opin Virol. 2013;3(4):452–460.
   PubMed Web of Science ®Google Scholar
• Carreno LJ, Gonzalez PA, Bueno SM, Riedel CA, Kalergis AM. Modulation of the dendritic cell-T-cell synapse to promote pathogen immunity and prevent autoimmunity. Immunotherapy. 2011;3(4s):6–11.
   PubMed Web of Science ®Google Scholar
• Schraml BUAC. Reis e Sousa, Defining dendritic cells. Curr Opin Immunol. 2015;32:13–20.
   PubMed Web of Science ®Google Scholar
• Bedoui S, Greyer M. The role of dendritic cells in immunity against primary herpes simplex virus infections. Front Microbiol. 2014;5:533.
   PubMed Web of Science ®Google Scholar
• Macri C, Pang ES, Patton T, O'Keeffe M. Dendritic cell subsets. Semin Cell Dev Biol. 2018;84:11–21.
   PubMed Web of Science ®Google Scholar
• Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. Int Rev Cell Mol Biol. 2019;348:1–68.
   PubMed Web of Science ®Google Scholar
• Segura E. Review of Mouse and Human Dendritic Cell Subsets. Methods Mol Biol. 2016;1423:3–15.
   PubMedGoogle Scholar
• Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31(1):563–604.
   PubMed Web of Science ®Google Scholar
• Patente TA, Pinho MP, Oliveira AA, Evangelista GCM, Bergami-Santos PC, Barbuto JAM. Human Dendritic Cells: their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Front Immunol. 2018;9:3176.
   PubMed Web of Science ®Google Scholar
• Bieber K, Autenrieth SE. Dendritic cell development in infection. Mol Immunol. 2020;121:111–117.
   PubMed Web of Science ®Google Scholar
• Chung NP, Chen Y, Chan VS, Tam PK, Lin CL. Dendritic cells: sentinels against pathogens. Histol Histopathol. 2004;19(1):317–324.
   PubMed Web of Science ®Google Scholar
• Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7–24.
   PubMed Web of Science ®Google Scholar
• Mikloska Z, Bosnjak L, Cunningham AL. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol. 2001;75(13):5958–5964.
   PubMed Web of Science ®Google Scholar
• Goldwich A, Prechtel AT, Muhl-Zurbes P, Pangratz NM, Stossel H, Romani N, et al. Herpes simplex virus type I (HSV-1) replicates in mature dendritic cells but can only be transferred in a cell-cell contact-dependent manner. J Leukoc Biol. 2011;89(6):973–979.
   PubMed Web of Science ®Google Scholar
• Grosche L, Muhl-Zurbes P, Ciblis B, Krawczyk A, Kuhnt C, Kamm L,et al. Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells. Viruses. 2020;12(1):112.
   Web of Science ®Google Scholar
• Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol. 1999;29(10):3245–3253.
   PubMed Web of Science ®Google Scholar
• Heilingloh CS, Krawczyk A. Role of L-Particles during Herpes Simplex Virus Infection. Front Microbiol. 2017;8:2565.
   PubMed Web of Science ®Google Scholar
• Heilingloh CS, Kummer M, Muhl-Zurbes P, Drassner C, Daniel C, Klewer M, et al. L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation. J Virol. 2015;89(21):11046–11055.
   PubMed Web of Science ®Google Scholar
• Birzer A, Krawczyk A, Drassner C, Kuhnt C, Muhl-Zurbes P, Heilingloh CS, et al. HSV-1 Modulates IL-6 Receptor Expression on Human Dendritic Cells. Front Immunol. 2020;11:1970.
   PubMed Web of Science ®Google Scholar
• Birzer A, Kraner ME, Heilingloh CS, Muhl-Zurbes P, Hofmann J, Steinkasserer A, et al. Mass Spectrometric Characterization of HSV-1 L-Particles From Human Dendritic Cells and BHK21 Cells and Analysis of Their Functional Role. Front Microbiol. 2020;11:1997.
   PubMed Web of Science ®Google Scholar
• Retamal-Diaz A, Weiss KA, Tognarelli EI, Freire M, Bueno SM, Herold BC, et al. US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation. Front Immunol. 2017;8:1523.
   PubMed Web of Science ®Google Scholar
• Donaghy H, Bosnjak L, Harman AN, Marsden V, Tyring SK, Meng TC,et al. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol. 2009;83(4):1952–1961.
   PubMed Web of Science ®Google Scholar
• Schuster P, Donhauser N, Pritschet K, Ries M, Haupt S, Kittan NA, et al. Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1. Immunology. 2010;129(2):234–247.
   PubMed Web of Science ®Google Scholar
• Schuster P, Thomann S, Werner M, Vollmer J, Schmidt B. A subset of human plasmacytoid dendritic cells expresses CD8alpha upon exposure to herpes simplex virus type 1. Front Microbiol. 2015;6:557.
   PubMed Web of Science ®Google Scholar
• Sprecher E, Becker Y. Skin Langerhans cells play an essential role in the defense against HSV-1 infection. Arch Virol. 1986;91(3–4):341–349.
   PubMed Web of Science ®Google Scholar
• Kim M, Truong NR, James V, Bosnjak L, Sandgren KJ, Harman AN, et al. Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin. PLoS Pathog. 2015;11(4):e1004812.
   PubMed Web of Science ®Google Scholar
• Kassim SH, Rajasagi NK, Zhao X, Chervenak R, Jennings SR. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol. 2006;80(8):3985-93.
   PubMed Web of Science ®Google Scholar
• Bertram KM, Truong NR, Smith JB, Kim M, Sandgren KJ, Feng KL, et al. Herpes Simplex Virus type 1 infects Langerhans cells and the novel epidermal dendritic cell, Epi-cDC2s, via different entry pathways. PLoS Pathog. 2021;17(4):e1009536.
   PubMed Web of Science ®Google Scholar
• Carenza C, Calcaterra F, Oriolo F, Di Vito C, Ubezio M, Della Porta MG, et al. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells. Front Immunol. 2019;10:1325.
   PubMed Web of Science ®Google Scholar
• Retamal-Diaz AR, Kalergis AM, Bueno SM, Gonzalez PA. A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4(+) and CD8(+) T Cells. Front Immunol. 2017;8:904.
   PubMed Web of Science ®Google Scholar
• Matundan H, Ghiasi H. Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells. J Virol. 2019;93(3):e01803-18.
   PubMed Web of Science ®Google Scholar
• Ma Y, Chen M, Jin H, Prabhakar BS, Valyi-Nagy T, He B. An Engineered Herpesvirus Activates Dendritic Cells and Induces Protective Immunity. Sci Rep. 2017;7(1):41461.
   PubMed Web of Science ®Google Scholar
• Grosche L, Knippertz I, Konig C, Royzman D, Wild AB, Zinser E, et al. The CD83 Molecule - An Important Immune Checkpoint. Front Immunol. 2020;11:721.
   PubMed Web of Science ®Google Scholar
• Kummer M, Turza NM, Muhl-Zurbes P, Lechmann M, Boutell C, Coffin RS, et al. Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome. J Virol. 2007;81(12):6326–6338.
   PubMed Web of Science ®Google Scholar
• Stefanidou M, Ramos I, Mas Casullo V, Trepanier JB, Rosenbaum S, Fernandez-Sesma A, et al. Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy. J Virol. 2013;87(3):1443–1453.
   PubMed Web of Science ®Google Scholar
• Heilingloh CS, Muhl-Zurbes P, Steinkasserer A, Kummer M. Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function. J Gen Virol. 2014;95(6):1366–1375.
   PubMed Web of Science ®Google Scholar
• Zuany-Amorim C, Hastewell J, Walker C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov. 2002;1(10):797–807.
   PubMed Web of Science ®Google Scholar
• Dowling JK, Mansell A. Toll-like receptors: the Swiss army knife of immunity and vaccine development. Clin Transl Immunology. 2016;5(5):e85.
   PubMed Web of Science ®Google Scholar
• Zheng W, Xu Q, Zhang Y, E X, Gao W, Zhang M, et al. Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways. Virol J. 2020;17(1):192.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, Kagan JC. Toll-like Receptors and the Control of Immunity. Cell. 2020;180(6):1044–1066.
   PubMed Web of Science ®Google Scholar
• Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A. 2006;103(46):17343–17348.
   PubMed Web of Science ®Google Scholar
• Ariza ME, Glaser R, Williams MV. Human herpesviruses-encoded dUTPases: a family of proteins that modulate dendritic cell function and innate immunity. Front Microbiol. 2014;5:504.
   PubMed Web of Science ®Google Scholar
• Williams MV, Cox B, Ariza ME. Herpesviruses dUTPases: a New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease. Pathogens. 2016;6(1):2.
   PubMed Web of Science ®Google Scholar
• Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198(3):513–520.
   PubMed Web of Science ®Google Scholar
• Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood. 2004;103(4):1433–1437.
   PubMed Web of Science ®Google Scholar
• Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A. 2004;101(31):11416–11421.
   PubMed Web of Science ®Google Scholar
• Jin H, Ma Y, Prabhakar BS, Feng Z, Valyi-Nagy T, Yan Z, et al. The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection. J Virol. 2009;83(10):4984–4994.
   PubMed Web of Science ®Google Scholar
• Jin H, Yan Z, Ma Y, Cao Y, He B. A herpesvirus virulence factor inhibits dendritic cell maturation through protein phosphatase 1 and Ikappa B kinase. J Virol. 2011;85(7):3397–3407.
   PubMed Web of Science ®Google Scholar
• Cotter CR, Kim WK, Nguyen ML, Yount JS, Lopez CB, Blaho JA, et al. The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-kappaB in dendritic cells in the absence of type I interferon signaling. J Virol. 2011;85(23):12662-12672.
   PubMed Web of Science ®Google Scholar
• Menachery VD, Leib DA. Control of herpes simplex virus replication is mediated through an interferon regulatory factor 3-dependent pathway. J Virol. 2009;83(23):12399–12406.
   PubMed Web of Science ®Google Scholar
• McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87–103.
   PubMed Web of Science ®Google Scholar
• Lazear HM, Schoggins JW, Diamond MS. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50(4):907–923.
   PubMed Web of Science ®Google Scholar
• Onomoto K, Onoguchi K, Yoneyama M. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol Immunol. 2021;18(3):539–555.
   PubMed Web of Science ®Google Scholar
• Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5(5):375–386.
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Rivera A, Parker D, Durbin JE. Type III IFNs: beyond antiviral protection. Semin Immunol. 2019;43:101303.
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36–49.
   PubMed Web of Science ®Google Scholar
• Mesev EV, LeDesma RA, Ploss A. Decoding type I and III interferon signalling during viral infection. Nat Microbiol. 2019;4(6):914–924.
   PubMed Web of Science ®Google Scholar
• Lee AJ, Ashkar AA. The Dual Nature of Type I and Type II Interferons. Front Immunol. 2018;9:2061.
   PubMed Web of Science ®Google Scholar
• Alandijany T. Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection. Front Microbiol. 2019;10:2611.
   PubMed Web of Science ®Google Scholar
• Negishi H, Taniguchi T, Yanai H. The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harb Perspect Biol. 2018;10(11):a028423.
   PubMed Web of Science ®Google Scholar
• Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV. Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria. Scand J Immunol. 1997;46(3):235–241.
   PubMed Web of Science ®Google Scholar
• Gary-Gouy H, Lebon P, Dalloul AH. Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J Interferon Cytokine Res. 2002;22(6):653–659.
   PubMed Web of Science ®Google Scholar
• Melchjorsen J, Siren J, Julkunen I, Paludan SR, Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J Gen Virol. 2006;87(5):1099–1108.
   PubMed Web of Science ®Google Scholar
• Pollara G, Jones M, Handley ME, Rajpopat M, Kwan A, Coffin RS, et al. Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. J Immunol. 2004;173(6):4108–4119.
   PubMed Web of Science ®Google Scholar
• Reske A, Pollara G, Krummenacher C, Katz DR, Chain BM. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J Immunol. 2008;180(11):7525–7536.
   PubMed Web of Science ®Google Scholar
• Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science. 2013;341(6152):1390–1394.
   PubMed Web of Science ®Google Scholar
• Ferenczy MW, DeLuca NA. Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0. J Virol. 2011;85(7):3424–3435.
   PubMed Web of Science ®Google Scholar
• Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB,et al. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol. 2008;180(4):2474–2485.
   PubMed Web of Science ®Google Scholar
• Rasmussen SB, Sorensen LN, Malmgaard L, Ank N, Baines JD, Chen ZJ, et al. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol. 2007;81(24):13315–13324.
   PubMed Web of Science ®Google Scholar
• Iversen MB, Ank N, Melchjorsen J, Paludan SR. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs. J Virol. 2010;84(9):4579–4586.
   PubMed Web of Science ®Google Scholar
• Tel J, Torensma R, Figdor CG, de Vries IJ. IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1. J Invest Dermatol. 2011;131(4):900–6.
   PubMed Web of Science ®Google Scholar
• Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, et al. Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Cell Res. 2012;22(7):1129–1139.
   PubMed Web of Science ®Google Scholar
• Kopfnagel V, Wagenknecht S, Harder J, Hofmann K, Kleine M, Buch A, et al. RNase 7 Strongly Promotes TLR9-Mediated DNA Sensing by Human Plasmacytoid Dendritic Cells. J Invest Dermatol. 2018;138(4):872–881.
   PubMed Web of Science ®Google Scholar
• Dai J, Megjugorac NJ, Amrute SB, Fitzgerald-Bocarsly P. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J Immunol. 2004;173(3):1535–1548.
   PubMed Web of Science ®Google Scholar
• Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214(5):1471–1491.
   PubMed Web of Science ®Google Scholar
• Swiecki M, Wang Y, Gilfillan S, Colonna M. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 2013;9(10):e1003728.
   PubMed Web of Science ®Google Scholar
• Bin L, Li X, Richers B, Streib JE, Hu JW, Taylor P, et al. Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: a potential role in eczema herpeticum. J Allergy Clin Immunol. 2018;141(6):2085–2093 e1.
   PubMed Web of Science ®Google Scholar
• Hatakeyama S. TRIM Family Proteins: roles in Autophagy, Immunity, and Carcinogenesis. Trends Biochem Sci. 2017;42(4):297–311.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lian Q, Yang B, Yan S, Zhou H, He L, et al. TRIM30alpha Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING. PLoS Pathog. 2015;11(6):e1005012. DOI:10.1371/journal.ppat.1005012.
   PubMed Web of Science ®Google Scholar
• Xing J, Zhang A, Zhang H, Wang J, Li XC, Zeng MS, et al. TRIM29 promotes DNA virus infections by inhibiting innate immune response. Nat Commun. 2017;8(1):945.
   PubMed Web of Science ®Google Scholar
• Shi M, Deng W, Bi E, Mao K, Ji Y, Lin G, et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol. 2008;9(4):369–377.
   PubMed Web of Science ®Google Scholar
• Jin H, Ma Y, Yan Z, Prabhakar BS, He B. Activation of NF-kappaB in CD8+ dendritic cells Ex Vivo by the gamma134.5 null mutant correlates with immunity against herpes simplex virus 1. J Virol. 2012;86(2):1059–68.
   PubMed Web of Science ®Google Scholar
• Eisemann J, Muhl-Zurbes P, Steinkasserer A, Kummer M. Infection of mature dendritic cells with herpes simplex virus type 1 interferes with the interferon signaling pathway. Immunobiology. 2007;212(9–10):877–886.
   PubMed Web of Science ®Google Scholar
• Mott KR, Underhill D, Wechsler SL, Town T, Ghiasi H. A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. Virol J. 2009;6(1):56.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
   PubMed Web of Science ®Google Scholar
• Behar SM, Briken V. Apoptosis inhibition by intracellular bacteria and its consequence on host immunity. Curr Opin Immunol. 2019;60(p):103–110.
   PubMed Web of Science ®Google Scholar
• Naderer T, Fulcher MC. Targeting apoptosis pathways in infections. J Leukoc Biol. 2018;103(2):275–285.
   PubMed Web of Science ®Google Scholar
• Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol; 2020 Nov;21(11):678-695. 
   Google Scholar
• D’Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582–592.
   PubMed Web of Science ®Google Scholar
• Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta. 2011;1813(4):521–531.
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303(5660):1010–1014.
   PubMed Web of Science ®Google Scholar
• Kushwah R, Hu J. Dendritic cell apoptosis: regulation of tolerance versus immunity. J Immunol. 2010;185(2):795–802.
   PubMed Web of Science ®Google Scholar
• Jones CA, Fernandez M, Herc K, Bosnjak L, Miranda-Saksena M, Boadle RA, et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J Virol. 2003;77(20):11139–11149.
   PubMed Web of Science ®Google Scholar
• Pollara G, Speidel K, Samady L, Rajpopat M, McGrath Y, Ledermann J, et al. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J Infect Dis. 2003;187(2):165–178.
   PubMed Web of Science ®Google Scholar
• Puttur FK, Fernandez MA, White R, Roediger B, Cunningham AL, Weninger W, et al. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J Immunol. 2010;185(1):477–487.
   PubMed Web of Science ®Google Scholar
• Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol. 2005;174(4):2220–2227.
   PubMed Web of Science ®Google Scholar
• Muller DB, Raftery MJ, Kather A, Giese T, Schonrich G. Frontline: induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus. Eur J Immunol. 2004;34(4):941–951. DOI:10.1002/eji.200324509.
   PubMed Web of Science ®Google Scholar
• Kather A, Raftery MJ, Devi-Rao G, Lippmann J, Giese T, Sandri-Goldin RM, et al. Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences. J Virol. 2010;84(2):1034–1046.
   PubMed Web of Science ®Google Scholar
• Yu X, He S. The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol J. 2016;13:77.
   PubMed Web of Science ®Google Scholar
• Himmelein S, Lindemann A, Sinicina I, Strupp M, Brandt T, Hufner K. Latent herpes simplex virus 1 infection does not induce apoptosis in human trigeminal Ganglia. J Virol. 2015;89(10):5747–5750.
   PubMed Web of Science ®Google Scholar
• Subramanian M, Hayes CD, Thome JJ, Thorp E, Matsushima GK, Herz J, et al. An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. J Clin Invest. 2014;124(3):1296–1308.
   PubMed Web of Science ®Google Scholar
• Ravanan P, Srikumar IF, Talwar P. Autophagy: the spotlight for cellular stress responses. Life Sci. 2017;188:53–67.
   PubMed Web of Science ®Google Scholar
• Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460–473.
   PubMed Web of Science ®Google Scholar
• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349–364.
   PubMed Web of Science ®Google Scholar
• Ghislat G, Lawrence T. Autophagy in dendritic cells. Cell Mol Immunol. 2018;15(11):944–952.
   PubMed Web of Science ®Google Scholar
• Lussignol M, Queval C, Bernet-Camard MF, Cotte-Laffitte J, Beau I, Codogno P, et al. The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR. J Virol. 2013;87(2):859–871.
   PubMed Web of Science ®Google Scholar
• Rasmussen SB, Horan KA, Holm CK, Stranks AJ, Mettenleiter TC, Simon AK, et al. Activation of autophagy by alpha-herpesviruses in myeloid cells is mediated by cytoplasmic viral DNA through a mechanism dependent on stimulator of IFN genes. J Immunol. 2011;187(10):5268–5276.
   PubMed Web of Science ®Google Scholar
• O’Connell D, Liang C. Autophagy interaction with herpes simplex virus type-1 infection. Autophagy. 2016;12(3):451–459.
   PubMed Web of Science ®Google Scholar
• Gobeil PA, Leib DA. Herpes simplex virus gamma34.5 interferes with autophagosome maturation and antigen presentation in dendritic cells. MBio. 2012;3(5):e00267–12.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016;21:29.
   PubMed Web of Science ®Google Scholar
• Duthorn A, Turan A, Drassner C, Muhl-Zurbes P, Heilingloh CS, Steinkasserer A, et al. siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells. J Vis Exp. 2019;(152): doi:10.3791/60190.
   PubMed Web of Science ®Google Scholar
• Korolchuk VI, Rubinsztein DC. Regulation of autophagy by lysosomal positioning. Autophagy. 2011;7(8):927–928.
   PubMed Web of Science ®Google Scholar
• Turan A, Grosche L, Krawczyk A, Muhl-Zurbes P, Drassner C, Duthorn A, et al. Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1. J Cell Biol. 2019;218(2):508–523.
   PubMed Web of Science ®Google Scholar
• Budida R, Stankov MV, Dohner K, Buch A, Panayotova-Dimitrova D, Tappe KA, et al. Herpes simplex virus 1 interferes with autophagy of murine dendritic cells and impairs their ability to stimulate CD8(+) T lymphocytes. Eur J Immunol. 2017;47(10):1819–1834.
   PubMed Web of Science ®Google Scholar
• Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity. 2010;32(2):227–239.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yin X, Stuart PM, Leib DA. Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology. mBio. 2015;6(6):e01426–15.
   PubMed Web of Science ®Google Scholar
• Koksal AR, Verne GN, Zhou Q. Endoplasmic reticulum stress in biological processing and disease. J Investig Med. 2021;69(2):309–315.
   PubMed Web of Science ®Google Scholar
• Hojmann Larsen A, Frandsen A, Treiman M. Upregulation of the SERCA-type Ca2+ pump activity in response to endoplasmic reticulum stress in PC12 cells. BMC Biochem. 2001;2:4.
   PubMed Web of Science ®Google Scholar
• Krebs J, Agellon LB, Michalak M. Ca(2+) homeostasis and endoplasmic reticulum (ER) stress: an integrated view of calcium signaling. Biochem Biophys Res Commun. 2015;460(1):114–121.
   PubMed Web of Science ®Google Scholar
• Volmer R, van der Ploeg K, Ron D. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proc Natl Acad Sci U S A. 2013;110(12):4628–4633.
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Hori O, Stern DM, Hartmann E, Ogawa S, Tohyama M. Stress-associated endoplasmic reticulum protein 1 (SERP1)/Ribosome-associated membrane protein 4 (RAMP4) stabilizes membrane proteins during stress and facilitates subsequent glycosylation. J Cell Biol. 1999;147(6):1195–1204.
   PubMed Web of Science ®Google Scholar
• Frakes AE, Dillin A. The UPR(ER): sensor and Coordinator of Organismal Homeostasis. Mol Cell. 2017;66(6):761–771.
   PubMed Web of Science ®Google Scholar
• Tirasophon W, Welihinda AA, Kaufman RJ. A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 1998;12(12):1812–1824.
   PubMed Web of Science ®Google Scholar
• Hetz C, Martinon F, Rodriguez D, Glimcher LH. The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol Rev. 2011;91(4):1219–1243.
   PubMed Web of Science ®Google Scholar
• Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 1999;397(6716):271–274.
   PubMed Web of Science ®Google Scholar
• Haze K, Yoshida H, Yanagi H, Yura T, Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell. 1999;10(11):3787–3799.
   PubMed Web of Science ®Google Scholar
• Salvagno C, Cubillos-Ruiz JR. The impact of endoplasmic reticulum stress responses in dendritic cell immunobiology. Int Rev Cell Mol Biol. 2019;349:153–176.
   PubMed Web of Science ®Google Scholar
• Iwakoshi NN, Pypaert M, Glimcher LH. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J Exp Med. 2007;204(10):2267–2275.
   PubMed Web of Science ®Google Scholar
• Zhu XM, Yao FH, Yao YM, Dong N, Yu Y, Sheng ZY. Endoplasmic reticulum stress and its regulator XBP-1 contributes to dendritic cell maturation and activation induced by high mobility group box-1 protein. Int J Biochem Cell Biol. 2012;44(7):1097–1105.
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35–46.
   PubMed Web of Science ®Google Scholar
• Osorio F, Tavernier SJ, Hoffmann E, Saeys Y, Martens L, Vetters J, et al. The unfolded-protein-response sensor IRE-1alpha regulates the function of CD8alpha+ dendritic cells. Nat Immunol. 2014;15(3):248–257.
   PubMed Web of Science ®Google Scholar
• Mahadevan NR, Anufreichik V, Rodvold JJ, Chiu KT, Sepulveda H, Zanetti M. Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8(+) T cell priming. PLoS One. 2012;7(12):e51845.
   PubMed Web of Science ®Google Scholar
• Rodvold JJ, Chiu KT, Hiramatsu N, Nussbacher JK, Galimberti V, Mahadevan NR, et al. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Sci Signal. 2017;10(482):eaah7177.
   PubMed Web of Science ®Google Scholar
• Tavernier SJ, Osorio F, Vandersarren L, Vetters J, Vanlangenakker N, Van Isterdael G, et al. Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival. Nat Cell Biol. 2017;19(6):698–710.
   PubMed Web of Science ®Google Scholar
• Fink SL, Jayewickreme TR, Molony RD, Iwawaki T, Landis CS, Lindenbach BD, et al. IRE1alpha promotes viral infection by conferring resistance to apoptosis. Sci Signal. 2017;10(482):eaai7814.
   PubMed Web of Science ®Google Scholar
• Burnett HF, Audas TE, Liang G, Lu RR. Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection. Cell Stress Chaperones. 2012;17(4):473–483.
   PubMed Web of Science ®Google Scholar
• Su A, Wang H, Li Y, Wang X, Chen D, Wu Z. Opposite Roles of RNase and Kinase Activities of Inositol-Requiring Enzyme 1 (IRE1) on HSV-1 Replication. Viruses. 2017;9(9):235.
   Web of Science ®Google Scholar
• Tiberio L, Del Prete A, Schioppa T, Sozio F, Bosisio D, Sozzani S. Chemokine and chemotactic signals in dendritic cell migration. Cell Mol Immunol. 2018;15(4):346–352.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shi G. Role of G protein-coupled receptors in control of dendritic cell migration. Biomed Res Int. 2014;2014:738253.
   PubMed Web of Science ®Google Scholar
• Sozzani S, Allavena P, D'Amico G, Luini W, Bianchi G, Kataura M, et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol. 1998;161(3):1083–1086.
   PubMed Web of Science ®Google Scholar
• Liu S, Wu J, Zhang T, Qian B, Wu P, Li L, et al. Complement C1q chemoattracts human dendritic cells and enhances migration of mature dendritic cells to CCL19 via activation of AKT and MAPK pathways. Mol Immunol. 2008;46(2):242–249.
   PubMed Web of Science ®Google Scholar
• Ring S, Pushkarevskaya A, Schild H, Probst HC, Jendrossek V, Wirsdorfer F, et al. Regulatory T cell-derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. J Immunol. 2015;194(8):3735–3744.
   PubMed Web of Science ®Google Scholar
• Legler DF, Krause P, Scandella E, Singer E, Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol. 2006;176(2):966–973.
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol. 2007;81(1):84–91.
   PubMed Web of Science ®Google Scholar
• Prechtel AT, Turza NM, Kobelt DJ, Eisemann JI, Coffin RS, McGrath Y, et al. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J Gen Virol. 2005;86(6):1645–1657.
   PubMed Web of Science ®Google Scholar
• Theodoridis AA, Prechtel AT, Turza NM, Zenke M, Steinkasserer A. Infection of human dendritic cells with herpes simplex virus type 1 dramatically diminishes the mRNA levels of the prostaglandin E(2) receptors EP2 and EP4. Immunobiology. 2007;212(9–10):827–838.
   PubMed Web of Science ®Google Scholar
• Worbs T, Hammerschmidt SI, Forster R. Dendritic cell migration in health and disease. Nat Rev Immunol. 2017;17(1):30–48.
   PubMed Web of Science ®Google Scholar
• Thapa M, Carr DJ. CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: uncoupling of CD8+ T-cell effector function but not migration. J Virol. 2009;83(18):9486–9501.
   PubMed Web of Science ®Google Scholar
• Hofer S, Pfeil K, Niederegger H, Ebner S, Nguyen VA, Kremmer E, et al. Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP. Blood. 2006;107(3):1003–1009.
   PubMed Web of Science ®Google Scholar
• Theodoridis AA, Eich C, Figdor CG, Steinkasserer A. Infection of dendritic cells with herpes simplex virus type 1 induces rapid degradation of CYTIP, thereby modulating adhesion and migration. Blood. 2011;118(1):107–115.
   PubMed Web of Science ®Google Scholar
• Wu B, Geng S, Bi Y, Liu H, Hu Y, Li X, et al. Herpes Simplex Virus 1 Suppresses the Function of Lung Dendritic Cells via Caveolin-1. Clin Vaccine Immunol. 2015;22(8):883–895.
   PubMedGoogle Scholar
• Parton RG, McMahon KA, Wu Y. Caveolae: formation, dynamics, and function. Curr Opin Cell Biol. 2020;65:8–16.
   PubMed Web of Science ®Google Scholar
• Navarro A, Anand-Apte B, Parat MO. A role for caveolae in cell migration. FASEB J. 2004;18(15):1801–1811.
   PubMed Web of Science ®Google Scholar
• Oyarce C, Cruz-Gomez S, Galvez-Cancino F, Vargas P, Moreau HD, Diaz-Valdivia N, et al. Caveolin-1 Expression Increases upon Maturation in Dendritic Cells and Promotes Their Migration to Lymph Nodes Thereby Favoring the Induction of CD8(+) T Cell Responses. Front Immunol. 2017;8:1794.
   PubMed Web of Science ®Google Scholar
• de Jong M, de Witte L, Bolmstedt A, van Kooyk Y, Geijtenbeek TBH. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J Gen Virol. 2008;89(10):2398–2409.
   PubMed Web of Science ®Google Scholar
• Smith CM, Belz GT, Wilson NS, Villadangos JA, Shortman K, Carbone FR, et al. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J Immunol. 2003;170(9):4437–4440.
   PubMed Web of Science ®Google Scholar
• Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol. 2012;12(8):557–569.
   PubMed Web of Science ®Google Scholar
• Nair-Gupta P, Blander JM. An updated view of the intracellular mechanisms regulating cross-presentation. Front Immunol. 2013;4:401.
   PubMed Web of Science ®Google Scholar
• Wang P, Kan Q, Yu Z, Li L, Zhang Z, Pan X, et al. Recombinant adenovirus expressing ICP47 gene suppresses the ability of dendritic cells by restricting specific T cell responses. Cell Immunol. 2013;282(2):129–135.
   PubMed Web of Science ®Google Scholar
• Bosnjak L, Jones CA, Abendroth A, Cunningham AL. Dendritic cell biology in herpesvirus infections. Viral Immunol. 2005;18(3):419–433.
   PubMed Web of Science ®Google Scholar
• Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science. 2003;301(5641):1925–1928.
   PubMed Web of Science ®Google Scholar
• Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity. 2006;25(1):153–162.
   PubMed Web of Science ®Google Scholar
• Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–593.
   PubMed Web of Science ®Google Scholar
• Jirmo AC, Nagel CH, Bohnen C, Sodeik B, Behrens GM. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1. J Immunol. 2009;182(1):283–292.
   PubMed Web of Science ®Google Scholar
• Davey GM, Wojtasiak M, Proietto AI, Carbone FR, Heath WR, Bedoui S. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J Immunol. 2010;184(5):2243–2246.
   PubMed Web of Science ®Google Scholar
• Whitney PG, Makhlouf C, MacLeod B, Ma JZ, Gressier E, Greyer M, et al. Effective Priming of Herpes Simplex Virus-Specific CD8(+) T Cells In Vivo Does Not Require Infected Dendritic Cells. J Virol. 2018;92(3): DOI:10.1128/JVI.01508-17.
   PubMed Web of Science ®Google Scholar
• Harpur CM, Kato Y, Dewi ST, Stankovic S, Johnson DN, Bedoui S, et al. Classical Type 1 Dendritic Cells Dominate Priming of Th1 Responses to Herpes Simplex Virus Type 1 Skin Infection. J Immunol. 2019;202(3):653–663.
   PubMed Web of Science ®Google Scholar
• Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A, et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med. 2005;202(3):425–435.
   PubMed Web of Science ®Google Scholar
• Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol. 2009;10(5):488–495.
   PubMed Web of Science ®Google Scholar
• Lee HK, Zamora M, Linehan MM, Iijima N, Gonzalez D, Haberman A, et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med. 2009;206(2):359–370.
   PubMed Web of Science ®Google Scholar
• Jiao Z, Bedoui S, Brady JL, Walter A, Chopin M, Carrington EM, et al. The closely related CD103+ dendritic cells (DCs) and lymphoid-resident CD8+ DCs differ in their inflammatory functions. PLoS One. 2014;9(3):e91126.
   PubMed Web of Science ®Google Scholar
• Allenspach EJ, Lemos MP, Porrett PM, Turka LA, Laufer TM. Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity. 2008;29(5):795–806.
   PubMed Web of Science ®Google Scholar
• Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature. 2011;477(7363):216–219.
   PubMed Web of Science ®Google Scholar
• Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol. 2004;4(8):595–602.
   PubMed Web of Science ®Google Scholar
• Hor JL, Whitney PG, Zaid A, Brooks AG, Heath WR, Mueller SN. Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection. Immunity. 2015;43(3):554–565.
   PubMed Web of Science ®Google Scholar
• Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J,et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med. 2003;197(2):153–162. DOI:10.1084/jem.20021109.
   PubMed Web of Science ®Google Scholar
• Bedoui S, Prato S, Mintern J, Gebhardt T, Zhan Y, Lew AM, et al. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. J Immunol. 2009;182(7):4200–4207.
   PubMed Web of Science ®Google Scholar
• Smith CM, Wilson NS, Waithman J, Villadangos JA, Carbone FR, Heath WR, et al. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat Immunol. 2004;5(11):1143–1148.
   PubMed Web of Science ®Google Scholar
• Rajasagi NK, Kassim SH, Kollias CM, Zhao X, Chervenak R, Jennings SR. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J Virol. 2009;83(10):5256–5268.
   PubMed Web of Science ®Google Scholar
• Bjorck P. Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity. J Immunol. 2004;172(9):5396–5404.
   PubMed Web of Science ®Google Scholar
• Gyotoku T, Ono F, Aurelian L. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK. Vaccine. 2002;20(21–22):2796–807.
   PubMed Web of Science ®Google Scholar
• Hua Y, Jiao YY, Ma Y, Peng XL, Fu YH, Zhang XJ, et al. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells. Int Immunopharmacol. 2017;46:62–69.
   PubMed Web of Science ®Google Scholar
• Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, et al. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med. 2010;2(25):25ra24.
   PubMed Web of Science ®Google Scholar
• Demoulins T, Englezou PC, Milona P, Ruggli N, Tirelli N, Pichon C, et al. Self-Replicating RNA Vaccine Delivery to Dendritic Cells. Methods Mol Biol. 2017;1499:37–75.
   PubMedGoogle Scholar
• Thery C, Amigorena S. The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol. 2001;13(1):45–51.
   PubMed Web of Science ®Google Scholar
• Ho NI, Huis In 't Veld LGM, Raaijmakers TK, Adema GJ. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: the Key to More Effective Vaccines? Front Immunol. 2018;9:2874.
   PubMed Web of Science ®Google Scholar
• Wahid R, Cannon MJ, Chow M. Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio. J Virol. 2005;79(10):5988–5995.
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity. 2010;33(4):464–478.
   PubMed Web of Science ®Google Scholar
• Yewdell JW, Norbury CC, Bennink JR. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol. 1999;73:1–77.
   PubMed Web of Science ®Google Scholar
• Tsitoura E, Kazazi D, Oz-Arslan D, Sever EA, Khalili S, Vassilaki N, et al. Comparison of Dendritic Cell Activation by Virus-Based Vaccine Delivery Vectors Emphasizes the Transcriptional Downregulation of the Oxidative Phosphorylation Pathway. Hum Gene Ther. 2019;30(4):429–445.
   PubMed Web of Science ®Google Scholar
• Yin W, Ouyang S, Li Y, Xiao B, Yang H. Immature dendritic cell-derived exosomes: a promise subcellular vaccine for autoimmunity. Inflammation. 2013;36(1):232–240.
   PubMed Web of Science ®Google Scholar
• Li X, Li JJ, Yang JY, Wang DS, Zhao W, Song WJ, et al. Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model. PLoS One. 2012;7(8):e44045.
   PubMed Web of Science ®Google Scholar
• Wang L, Yu Z, Wan S, Wu F, Chen W, Zhang B, et al. Exosomes Derived from Dendritic Cells Treated with Schistosoma japonicum Soluble Egg Antigen Attenuate DSS-Induced Colitis. Front Pharmacol. 2017;8:651.
   PubMed Web of Science ®Google Scholar
• Takenaka MC, Quintana FJ. Tolerogenic dendritic cells. Semin Immunopathol. 2017;39(2):113–120.
   PubMed Web of Science ®Google Scholar
• Chen P, Liu X, Sun Y, Zhou P, Wang Y, Zhang Y. Dendritic cell targeted vaccines: recent progresses and challenges. Hum Vaccin Immunother. 2016;12(3):612–622.
   PubMed Web of Science ®Google Scholar
• Nascimento IP, Leite LC. Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res. 2012;45(12):1102–1111.
   PubMed Web of Science ®Google Scholar
• Pinschewer DD. Virally vectored vaccine delivery: medical needs, mechanisms, advantages and challenges. Swiss Med Wkly. 2017;147:w14465.
   PubMed Web of Science ®Google Scholar
• Lee J, Arun Kumar S, Jhan YY, Bishop CJ. Engineering DNA vaccines against infectious diseases. Acta Biomater. 2018;80:31–47.
   PubMed Web of Science ®Google Scholar
• Kang TH, Lee JH, Bae HC, Noh KH, Kim JH, Song CK, et al. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments. Immunol Lett. 2006;106(2):126–134.
   PubMed Web of Science ®Google Scholar
• Smith TR, Schultheis K, Kiosses WB, Amante DH, Mendoza JM, Stone JC, et al. DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response. Mol Ther Methods Clin Dev. 2014;1:14054.
   PubMed Web of Science ®Google Scholar
• Glass JJ, Kent SJ, De Rose R. Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination. Expert Rev Vaccines. 2016;15(6):719–729.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Frenck RW, Jr., Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020;383(25):2439–2450.
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity. 2010;33(4):492–503.
   PubMed Web of Science ®Google Scholar
• Slifka MK, Amanna I. How advances in immunology provide insight into improving vaccine efficacy. Vaccine. 2014;32(25):2948–2957.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, et al. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis. 2011;203(5):666–673.
   PubMed Web of Science ®Google Scholar
• Stanley M. HPV vaccines: alternative dosage schedules. Expert Rev Vaccines. 2019;18(12):1309–1316.
   PubMed Web of Science ®Google Scholar
• Paulke-Korinek M, Kollaritsch H, Kundi M, Zwazl I, Seidl-Friedrich C, Jelinek T. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis. Vaccine. 2015;33(30):3600–3604.
   PubMed Web of Science ®Google Scholar
• Yeh MT, Bujaki E, Dolan PT, Smith M, Wahid R, Konz J, et al. Engineering the live-attenuated polio vaccine to prevent reversion to virulence. Cell Host Microbe. 2020;27(5):736–751 e8.
   PubMed Web of Science ®Google Scholar
• Enjuanes L, Zuniga S, Castano-Rodriguez C, Gutierrez-Alvarez J, Canton J, Sola I. Molecular basis of coronavirus virulence and vaccine development. Adv Virus Res. 2016;96:245–286.
   PubMed Web of Science ®Google Scholar
• Jones CA, Cunningham AL. Development of prophylactic vaccines for genital and neonatal herpes. Expert Rev Vaccines. 2003;2(4):541–549.
   PubMedGoogle Scholar
• Ferenczy MW. Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus. Curr Pharm Des. 2007;13(19):1975–1988.
   PubMed Web of Science ®Google Scholar
• Coleman JL, Shukla D. Recent advances in vaccine development for herpes simplex virus types I and II. Hum Vaccin Immunother. 2013;9(4):729–735.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, et al. Correlate of immune protection against HSV-1 genital disease in vaccinated women. J Infect Dis. 2014;209(6):828–836.
   PubMed Web of Science ®Google Scholar
• Ramsey NLM, Visciano M, Hunte R, Loh LN, Burn Aschner C, Jacobs WR, Jr., et al. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, DeltagD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus. J Virol. 2020;94(13): DOI:10.1128/JVI.00335-20.
   PubMed Web of Science ®Google Scholar
• Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, Gonzalez PA. Herpes simplex virus evasion of early host antiviral responses. Front Cell Infect Microbiol. 2019;9:127.
   PubMed Web of Science ®Google Scholar
• de Bruyn G, Vargas-Cortez M, Warren T, Tyring SK, Fife KH, Lalezari J, et al. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine. 2006;24(7):914–920.
   PubMed Web of Science ®Google Scholar
• Speck PG, Efstathiou S, Minson AC. In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector. J Gen Virol. 1996;77(10):2563–2568.
   PubMed Web of Science ®Google Scholar
• Petro C, Gonzalez PA, Cheshenko N, Jandl T, Khajoueinejad N, Benard A, et al. Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease. Elife. 2015;4: DOI:10.7554/eLife.06054.
   PubMed Web of Science ®Google Scholar
• Petro CD, Weinrick B, Khajoueinejad N, Burn C, Sellers R, Jacobs WR, Jr., et al. HSV-2 DeltagD elicits FcgammaR-effector antibodies that protect against clinical isolates. JCI Insight. 2016;1(12):e88529.
   PubMed Web of Science ®Google Scholar
• Burn Aschner C, Loh LN, Galen B, Delwel I, Jangra RK, Garforth SJ, et al. HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses. Sci Immunol. 2020;5(50):eaax2454.
   PubMed Web of Science ®Google Scholar